Jiangxi Zhongcheng Pharmaceutical Group Co., Ltd. is a large comprehensive veterinary drug production enterprise integrating research and development, production, sales, and technical services. It is one of the earliest domestic manufacturers of traditional Chinese veterinary medicine injections. Adhering to the purpose of "excavating the heritage of Chinese medicine and dedicating efficient green livestock and poultry medicines," the innovation concept of "applying modern science and technology for independent innovation to develop the traditional Chinese medicine industry," and the goal of "promoting the traditional advantages of Chinese medicine and building a brand enterprise image," the company is fully committed to promoting the healthy development of the traditional Chinese veterinary medicine industry.
In 1974, Jiangxi Veterinary Drug Factory was established;
In 2003, it was renamed Jiangxi Zhongcheng Animal Pharmaceutical Co., Ltd., Jiangxi Zhongcheng Pharmaceutical Group was established, and Jiangxi Zhongcheng Traditional Chinese Medicine Raw Materials Co., Ltd., Jiangxi Zhongchengren Pharmaceutical Co., Ltd., and Jiangxi Zhongcheng Epidemic Prevention High-Tech Co., Ltd. were formed.
In 2006, the company was renamed Jiangxi Zhongcheng Pharmaceutical Group Co., Ltd.
In 2007, it was an outstanding leading enterprise in agriculture and rural work in Nanchang City;
In 2007, it was selected as one of the Top 50 Chinese veterinary preparation manufacturing enterprises;
In 2008, it was an outstanding leading enterprise in agriculture and rural work in Nanchang City;
In 2009, it was a municipal-level leading enterprise in agricultural industrialization in Nanchang City;
In 2010, it was rated as an innovative pilot enterprise in Nanchang City;
In 2010, it was the only enterprise in Jiangxi Province selected as one of the Top 30 Chinese veterinary preparation manufacturing enterprises;
In 2008, the national Class III new veterinary drug "Shuanghuanglian for Injection" — the first new veterinary drug certificate for traditional Chinese veterinary medicine powder injection in China;
In 2008, the Nanchang Municipal Science and Technology Bureau designated it as the "Traditional Chinese Veterinary Medicine Preparation Engineering Technology Research Center";
In 2009, it was a participating unit in the 11th Five-Year National Science and Technology Support Program project "Research and Development of Modernization Technology for Traditional Chinese Veterinary Medicine";
In 2009, it undertook the drafting of some standards for the traditional Chinese medicine section of the 2010 edition of the Chinese Veterinary Pharmacopoeia;
In 2010, Qibanqing Granules and GanJunLing Oral Liquid won the title of Jiangxi Province Characteristic Traditional Chinese Medicine Products.
It has independently developed 37 products with independent intellectual property rights, among which 9 products have applied for national invention patents, and the products in the publicity period are Maxingshigan Injection and Qibanqing Granules.
The products have advantages such as "one small" (small dosage), "three noes" (no drug residues, no toxicity, no side effects), "three effects" (high efficiency, quick effect, long-lasting effect), and "three conveniences" (convenient storage, convenient transportation, convenient administration).
The company attaches importance to the cultivation and introduction of talents. With emphasis on moral character, ability, and performance as the criteria for selecting talents, it provides a platform for all kinds of talents to display their personal talents and reflect the value of life. The company supports employees in continuing their studies and further education, deeply taps employee potential, and continuously improves the quality of the company's personnel team.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows